Cancer cells experience an increase in hypoxia-induced aerobic glycolysis and associated kinase pyruvate kinase isozyme type 2 (PKM2), which can potentially counteract platinum-induced reactive oxygen species (ROS) and indirectly inhibit apoptosis to promote cisplatin resistance [46]. The gene discussed is PKM; the disease is cancer.